Economic Evaluation of Genomic Test–Directed Chemotherapy for Early-Stage Lymph Node–Positive Breast Cancer

Cost-Effectiveness Analysis of KRAS Testing and Cetuximab as Last-Line Therapy for Colorectal Cancer

(2012) Takeru Shiroiwa et al.   Molecular Diagnosis & Therapy

Updated Cost-Effectiveness Analysis of Trastuzumab for Early Breast Cancer

(2011) Peter S. Hall et al.   PHARMACOECONOMICS

Metastatic Potential of T1 Breast Cancer can be Predicted by the 70-gene MammaPrint Signature

(2010) Stella Mook et al.   ANNALS OF SURGICAL ONCOLOGY

Health economics in drug development: Efficient research to inform healthcare funding decisions

(2010) Peter S. Hall et al.   EUROPEAN JOURNAL OF CANCER

Researchers Consider Value-of-Information Theory for Selecting Trials

(2010) C. Schmidt   JNCI-Journal of the National Cancer Institute

Cost-Effectiveness Analysis of Recurrence Score-Guided Treatment Using a 21-Gene Assay in Early Breast Cancer

(2010) D. T. Tsoi et al.   ONCOLOGIST

An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial

(2009) Paula K. Lorgelly et al.   EUROPEAN JOURNAL OF HEART FAILURE

Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735

(2009) Stephen Jones et al.   JOURNAL OF CLINICAL ONCOLOGY

Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

(2009) Joel S. Parker et al.   JOURNAL OF CLINICAL ONCOLOGY

Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial

(2009) N. Mittmann et al.   JNCI-Journal of the National Cancer Institute

Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial

(2009) Kathy S Albain et al.   LANCET

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

(2009) Kathy S Albain et al.   LANCET ONCOLOGY